Research ExplorerScientific StaffChristina Rolling

Dr.med. ID: 56399

Christina Rolling

graph of relations
Affiliations

Publications

Effect of factor XI inhibition on tumor cell-induced coagulation activation

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Regulation of coagulation activation in newly diagnosed AML by the heme enzyme myeloperoxidase

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Absence of Malaria-Associated Coagulopathy in Asymptomatic Plasmodium falciparum Infection: Results From a Cross-sectional Study in the Ashanti Region, Ghana

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

P2Y12 Inhibition Suppresses Proinflammatory Platelet-Monocyte Interactions

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Platelet-monocyte aggregates: molecular mediators of thromboinflammation

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Inhibition of protein disulfide isomerase with PACMA-31 regulates monocyte tissue factor through transcriptional and posttranscriptional mechanisms

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Evaluation of different diagnostic tools for detection of acquired von Willebrand syndrome in patients with polycythemia vera or essential thrombocythemia

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression

Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (28)

projects

Stipendium DFG

Project: Research

View all (1)